Found: 12
Select item for more details and to access through your institution.
Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain.
- Published in:
- Advances in Therapy, 2010, v. 27, n. 6, p. 381, doi. 10.1007/s12325-010-0036-3
- By:
- Publication type:
- Article
Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 10, p. 2279, doi. 10.1007/s13555-023-01002-1
- By:
- Publication type:
- Article
Long-term Safety and Tolerability of Tapentadol Extended Release for the Management of Chronic Low Back Pain or Osteoarthritis Pain.
- Published in:
- Pain Practice, 2010, v. 10, n. 5, p. 416, doi. 10.1111/j.1533-2500.2010.00397.x
- By:
- Publication type:
- Article
Assessment of the Pharmacokinetics and Safety of Spesolimab, a Humanised Anti-interleukin-36 Receptor Monoclonal Antibody, in Healthy Non-Japanese and Japanese Subjects: Results from Phase I Clinical Studies.
- Published in:
- Clinical Pharmacokinetics, 2022, v. 61, n. 12, p. 1771, doi. 10.1007/s40262-022-01176-5
- By:
- Publication type:
- Article
Poster 66: Tapentadol Extended Release for the Relief of Chronic Pain Associated With Osteoarthritis of the Knee: Assessment of Opioid Withdrawal From a Randomized, Active‐ and Placebo‐controlled Study.
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Poster 44: Evaluation of Opioid Physical Dependence in Patients Treated With Tapentadol Extended Release or Oxycodone Controlled Release for Chronic Low Back or Osteoarthritis Pain: Results of a 1‐Year Safety Study.
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Poster 44: Evaluation of Opioid Physical Dependence in Patients Treated With Tapentadol Extended Release or Oxycodone Controlled Release for Chronic Low Back or Osteoarthritis Pain: Results of a 1-Year Safety Study
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Poster 66: Tapentadol Extended Release for the Relief of Chronic Pain Associated With Osteoarthritis of the Knee: Assessment of Opioid Withdrawal From a Randomized, Active- and Placebo-controlled Study
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Pharmacokinetics and Safety of Spesolimab in Healthy Chinese Subjects: An Open-Label, Phase I Study.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 9, p. 3557, doi. 10.1007/s12325-024-02940-8
- By:
- Publication type:
- Article
Safety and Tolerability of Tapentadol Extended Release in Moderate to Severe Chronic Osteoarthritis or Low Back Pain Management: Pooled Analysis of Randomized Controlled Trials.
- Published in:
- Advances in Therapy, 2014, v. 31, n. 6, p. 604, doi. 10.1007/s12325-014-0128-6
- By:
- Publication type:
- Article
Errata to: Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Erratum to: Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain.
- Published in:
- 2010
- By:
- Publication type:
- Correction Notice